FY26-27 Adult Covid-19 Vaccines

The CDC Office of Acquisition Services, under the Department of Health and Human Services, has awarded a Firm-Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract for the procurement of adult COVID-19 vaccines spanning the 2025–2026 and 2026–2027 immunization seasons. The contract, issued under solicitation number 75D301-26-R-73405 and NAICS code 325412, is designed to support state and local immunization programs by securing vaccines at prices below commercial market rates, with a maximum potential contract value of $892,363,500. Performance is centered in Atlanta, Georgia, with deliveries required to CDC’s centralized distribution hubs in Olive Branch, Mississippi, and Clermont, Kentucky, and potentially to five designated occupational health clinics. All vaccines must be delivered F.O.B. destination within fifteen working days of receiving an order, adhering to strict cold chain parameters including ambient, refrigerated, frozen, and ultra-cold temperature ranges, with mandatory documentation of any temperature excursions and supporting stability data. Contractors must comply with extensive regulatory, packaging, and documentation requirements, including full adherence to FDA Current Good Manufacturing Practices, Drug Supply Chain Security Act (DSCSA) traceability protocols, and Prescription Drug Marketing Act (PDMA) rules, with CDC serving as the Authorized Distributor of Record. Each shipment must include NDC codes in 5-4-2 format, lot numbers, expiration dates, and complete DSCSA transaction documentation (TI, TH, TS), and be packaged with one NDC per skid under consistent lot number control. Pricing is tied to the Federal Ceiling Price established by the Department of Veterans Affairs, and contractors must submit accurate commercial price lists and Federal Excise Tax details. Invoicing must be conducted electronically via EDI, with payment handled by the CDC Office of Financial Resources in Atlanta. Offerors are evaluated on technical capability, price, and past performance without a formal scoring system, and awards are made based on overall advantage to the government. Mandatory representations include SAM registration, small business status disclosures, and Section 508 accessibility compliance for any ICT-related deliverables, while special requirements include interfacing with CDC’s Vaccine Tracking System (VTrckS), submitting product images and safety data sheets, and providing uninterrupted documentation updates throughout the contract term. The contract includes numerous FAR clauses with deviations